company background image
A012790 logo

Sinil Pharmaceutical KOSDAQ:A012790 Stock Report

Last Price

₩7.36k

Market Cap

₩83.7b

7D

1.1%

1Y

-10.4%

Updated

28 Mar, 2024

Data

Company Financials

Sinil Pharmaceutical Co., Ltd.

KOSDAQ:A012790 Stock Report

Market Cap: ₩83.7b

A012790 Stock Overview

Sinil Pharmaceutical Co., Ltd. manufactures and sells pharmaceutical products in South Korea and internationally.

A012790 fundamental analysis
Snowflake Score
Valuation4/6
Future Growth0/6
Past Performance3/6
Financial Health6/6
Dividends1/6

Sinil Pharmaceutical Co., Ltd. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Sinil Pharmaceutical
Historical stock prices
Current Share Price₩7,360.00
52 Week High₩8,660.00
52 Week Low₩6,280.00
Beta1.52
1 Month Change7.60%
3 Month Change-4.54%
1 Year Change-10.35%
3 Year Change-42.03%
5 Year Change9.84%
Change since IPO580.76%

Recent News & Updates

Recent updates

Are Sinil Pharmaceutical Co., Ltd.'s (KOSDAQ:012790) Mixed Financials Driving The Negative Sentiment?

Mar 11
Are Sinil Pharmaceutical Co., Ltd.'s (KOSDAQ:012790) Mixed Financials Driving The Negative Sentiment?

Is Sinil Pharmaceutical's (KOSDAQ:012790) 122% Share Price Increase Well Justified?

Feb 13
Is Sinil Pharmaceutical's (KOSDAQ:012790) 122% Share Price Increase Well Justified?

Could The Sinil Pharmaceutical Co., Ltd. (KOSDAQ:012790) Ownership Structure Tell Us Something Useful?

Jan 17
Could The Sinil Pharmaceutical Co., Ltd. (KOSDAQ:012790) Ownership Structure Tell Us Something Useful?

Sinil Pharmaceutical's (KOSDAQ:012790) Earnings Are Growing But Is There More To The Story?

Dec 22
Sinil Pharmaceutical's (KOSDAQ:012790) Earnings Are Growing But Is There More To The Story?

Are Sinil Pharmaceutical Co., Ltd.'s (KOSDAQ:012790) Mixed Financials The Reason For Its Gloomy Performance on The Stock Market?

Nov 26
Are Sinil Pharmaceutical Co., Ltd.'s (KOSDAQ:012790) Mixed Financials The Reason For Its Gloomy Performance on The Stock Market?

Shareholder Returns

A012790KR PharmaceuticalsKR Market
7D1.1%4.3%2.4%
1Y-10.4%28.2%12.2%

Return vs Industry: A012790 underperformed the KR Pharmaceuticals industry which returned 28.2% over the past year.

Return vs Market: A012790 underperformed the KR Market which returned 12.2% over the past year.

Price Volatility

Is A012790's price volatile compared to industry and market?
A012790 volatility
A012790 Average Weekly Movement3.0%
Pharmaceuticals Industry Average Movement4.9%
Market Average Movement5.2%
10% most volatile stocks in KR Market11.9%
10% least volatile stocks in KR Market2.4%

Stable Share Price: A012790 has not had significant price volatility in the past 3 months.

Volatility Over Time: A012790's weekly volatility (3%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1971n/aMi-Keun Junghttps://www.sinilpharm.com

Sinil Pharmaceutical Co., Ltd. manufactures and sells pharmaceutical products in South Korea and internationally. It offers pharmaceutical products for various indications, such as pain reliever, anti-inflammatory, hyperlipidemia, skin disease, and folic acid deficiency; and general/specialty drugs, veterinary drugs, and OEM products for various diseases. The company also provides cosmetics, including skin care products, etc.; health functional products comprising vitamin supplements; and quasi-drugs for yellow dust, bacteria blocking, etc. In addition, it is involved in the real estate rental services.

Sinil Pharmaceutical Co., Ltd. Fundamentals Summary

How do Sinil Pharmaceutical's earnings and revenue compare to its market cap?
A012790 fundamental statistics
Market cap₩83.73b
Earnings (TTM)₩13.64b
Revenue (TTM)₩89.14b

6.1x

P/E Ratio

0.9x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
A012790 income statement (TTM)
Revenue₩89.14b
Cost of Revenue₩51.56b
Gross Profit₩37.57b
Other Expenses₩23.93b
Earnings₩13.64b

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)1.20k
Gross Margin42.15%
Net Profit Margin15.30%
Debt/Equity Ratio0%

How did A012790 perform over the long term?

See historical performance and comparison

Dividends

2.3%

Current Dividend Yield

n/a

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.